Arvinas to collaborate with Pfizer on protein degradation drugs

05-01-2018

Arvinas to collaborate with Pfizer on protein degradation drugs

no_limit_pictures / iStockphoto.com

Biotech company Arvinas has announced a multi-year research collaboration and licence agreement with global pharmaceutical corporation Pfizer.


Healthcare, Biotech, Pharmaceuticals, Technology, Arvinas, Pfizer, protein drugs, protac, clinical trial, research and development

LSIPR